| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,166 |
5,085 |
$488K |
| 99401 |
|
7,695 |
6,314 |
$188K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,454 |
3,028 |
$171K |
| 99354 |
|
808 |
689 |
$43K |
| 99406 |
|
3,444 |
2,881 |
$34K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
889 |
763 |
$33K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
125 |
117 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
566 |
463 |
$11K |
| 93000 |
|
514 |
486 |
$6K |
| 99496 |
|
28 |
24 |
$5K |
| 99215 |
Prolong outpt/office vis |
31 |
30 |
$4K |
| 99408 |
|
132 |
92 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,063 |
962 |
$2K |
| 87481 |
|
41 |
41 |
$2K |
| 82948 |
|
707 |
552 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
38 |
38 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
50 |
50 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
13 |
$1K |
| 81000 |
|
522 |
460 |
$1K |
| 93922 |
|
26 |
13 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
24 |
24 |
$831.84 |
| 94060 |
|
12 |
12 |
$628.65 |
| 81003 |
|
377 |
371 |
$519.69 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
18 |
$225.44 |
| 90749 |
|
13 |
13 |
$109.33 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16 |
13 |
$79.32 |
| 97802 |
|
66 |
57 |
$61.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
33 |
27 |
$10.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17 |
14 |
$3.69 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
588 |
480 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
64 |
55 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,422 |
1,176 |
$0.00 |